Literature DB >> 2856462

Cytolytic hepatitis with captopril but not with enalapril.

F Zannad, P Y Marie, E Aliot, P Trechot, J M Gilgenkrantz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2856462     DOI： 10.1007/bf02125754

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  6 in total

1.  Absence of cross-reactivity between captopril and enalapril.

Authors:  G J Navis; P E de Jong; C G Kallenberg; J de Monchy; D de Zeeuw
Journal:  Lancet       Date:  1984-05-05       Impact factor: 79.321

2.  Reversible cholestatic jaundice and hyperamylasaemia associated with captopril treatment.

Authors:  A Zimran; A S Abraham; C Hershko
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03

3.  [Hepatitis due to captopril].

Authors:  J P Ryckelynck; J M Batho; J Peny; P Beuve-Mery
Journal:  Nouv Presse Med       Date:  1982-05-29

4.  Hepatitis associated with captopril treatment.

Authors:  M Vandenburg; P Parfrey; P Wright; E Lazda
Journal:  Br J Clin Pharmacol       Date:  1981-01       Impact factor: 4.335

5.  Captopril-induced cholestatic jaundice.

Authors:  W A Parker
Journal:  Drug Intell Clin Pharm       Date:  1984-03

6.  Captopril-associated cholestatic jaundice.

Authors:  J Rahmat; R L Gelfand; M C Gelfand; J F Winchester; G E Schreiner; H J Zimmerman
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.